Compare the duration of pain relief after giving injection bupivacaine or injection ropivacaine in patients after abdominal surgeries
Phase 3
- Conditions
- Health Condition 1: K00-K95- Diseases of the digestive systemHealth Condition 2: N00-N99- Diseases of the genitourinary systemHealth Condition 3: C00-D49- NeoplasmsHealth Condition 4: O00-O9A- Pregnancy, childbirth and the puerperium
- Registration Number
- CTRI/2018/10/016137
- Lead Sponsor
- IGIMS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient of physical status 1&2
Patient willing to participate
Patient undergoing open abdominal surgery
Exclusion Criteria
Patient refusal to participate
Patient with known sensitivity to local anesthetics
Patient with infection at injection site
patient with clotting abnormalities
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the efficacy ofUSG guided TAP block with 0.25% bupivacaine and 0.25% ropivacaine for postoperative analgesia in open abdominal surgeriesTimepoint: 0,2,4,6,8,10,12,16,20,24 hours
- Secondary Outcome Measures
Name Time Method To look for any significant adverse effect of these drugsTimepoint: 0,2,4,6,8,10,12,16,20,24 hours